DNA, FDA Approval and Nurses - Drug Discovery Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

DNA

FDA Approval

Nurses

Topical Gene Therapy FDA-Approved for Severe Skin Disease, Dystrophic Epidermolysis Bullosa

PLOS: DNA Science

JUNE 1, 2023

The newest FDA-approved gene therapy treats the severe, skin-peeling condition dystrophic epidermolysis bullosa (DEB). The gene treatment has been a long time coming, but it differs from the handful of other approved gene therapies: it isn’t a one-and-done. This DNA Science post from 2018 traces the history of the efforts.

FDA Approval

FDA Approval Therapies FDA Disease

The Long Road to End Tuberculosis

Codon

NOVEMBER 3, 2024

Some fluoroquinolones — a class of antibiotics that inhibits DNA replication — may even cause psychosis. These challenges have led to strategies such as directly observed therapy (DOT), in which nurses or physicians monitor patients to ensure they take their medicine every day. coli bacteria from growing.

Vaccine

Vaccine Trials Therapies Treatment

Topical Gene Therapy FDA-Approved for Severe Skin Disease, Dystrophic Epidermolysis Bullosa

The Long Road to End Tuberculosis

Stay Connected